Recently, a novel biomarker called carbonic anhydrase II, which can promote tumor growth by contributing to intracellular alkalization and extracelluar acidification, has been demonstrated to be quite selective to GISTs among mesenchymal tumors [16]. This evidence concerns the gene CA2 and mesenchymal cell neoplasm.